Journal of Substance Abuse Treatment
Volume 31, Issue 1 , Pages 95-105 , July 2006

Outcomes and costs of matching the intensity of dual-diagnosis treatment to patients' symptom severity

Received 23 May 2005 ,Revised 1 March 2006 ,Accepted 22 March 2006.

References 

  1. Agha Z, Lofgren RP, VanRuiswyk JV, Layde PM. Are patients at veterans affairs medical centers sicker?. Archives of Internal Medicine. 2000;160:3252–3257
  2. Alterman AI, McLellan AT, Shifman RB. Do substance abuse patients with more psychopathology receive more treatment?. Journal of Nervous and Mental Disease. 1993;181:576–582
  3. Alterman AI, Mulvaney FD, Cacciola JS, Cnaan A, McDermott PA, Brown LS. The validity of the interviewer severity ratings in groups of ASI interviewers with varying training. Addiction. 2001;96:1297–1305
  4. Avants SK, Margolin A, Koston TR, Rounsaville BJ, Schottenfeld RS. When is less treatment better?. Journal of Consulting and Clinical Psychology. 1998;66:924–931
  5. Barnett PG. The cost-effectiveness of substance abuse treatment. Current Psychiatry Reports. 1999;1:166–171
  6. Barnett PG. Determination of VA health care costs. Medical Care Research and Review. 2003;60:124S–141S
  7. Bauer M, McBride L. The life goals program: Structured group psychotherapy for bipolar disorder. New York: Springer; 1996;
  8. Bauer MS, Shea N, McBride L, Gavin C. Predictors of service utilization in veterans with bipolar disorder: A prospective study. Journal of Affective Disorders. 1997;44:159–168
  9. Booth BM, Cook CA, Blow FC, Bunn JY. Utilization of outpatient mental health services after inpatient alcoholism treatment. Journal of Mental Health Administration. 1992;19:21–30
  10. Burnam MA, Morton SC, McGlynn EA, Petersen LP, Stecher BM, Hayes C, et al. An experimental evaluation of residential and nonresidential treatment for dually diagnosed homeless adults. Journal of Addictive Disease. 1995;14:111–134
  11. Calsyn DA, Saxo AJ, Blaes P, Lee-Meyer S. Staffing patterns of American methadone maintenance programs. Journal of Substance Abuse Treatment. 1990;7:255–259
  12. Carroll KM, Rounsaville BJ, Gordon LT, Nich C, Jatlow P, Bisighini RM, et al. Psychotherapy and pharmacotherapy for ambulatory cocaine abusers. Archives of General Psychiatry. 1994;51:177–187
  13. Cartwright WS. Cost–benefit analysis of drug treatment services: Review of the literature?. Journal of Mental Health Policy and Economics. 2000;3:11–26
  14. Curran GM, Kirchner JE, Worley M, Rookey C, Booth BM. Depressive symptomatology and early attrition from intensive outpatient substance use treatment. Journal of Behavioral Health Services & Research. 2002;29:138–143
  15. Dismuke CE, French MT, Solome HJ, Foss MA, Scott CK, Dennis ML. Out of touch or on the money: Do the clinical objectives of addiction treatment coincide with economic evaluation results?. Journal of Substance Abuse Treatment. 2004;27:253–263
  16. Drake RE, Mueser KT, Clark RE, Wallach MA. The course, treatment, and outcome of substance disorder in persons with severe mental illness. American Journal of Orthopsychiatry. 1996;66:42–51
  17. Evers SM, Van Wijik AS, Ament AJ. Economic evaluation of mental health care interventions: A review. Health Economics. 1997;6:161–177
  18. French MT, Mauskopf JA, Teague JL, Roland EJ. Estimating the dollar value of health outcomes from drug-abuse interventions. Medical Care. 1996;34:890–910
  19. Friedman MJ, West AN. Current need versus treatment history as predictors of use of outpatient psychiatric care. American Journal of Psychiatry. 1987;144:355–357
  20. Fureman I, McLellan AT, Alterman A. Training for and maintaining interviewer consistency with the ASI. Journal of Substance Abuse Treatment. 1994;11:233–237
  21. Geller JL, Fisher WH, McDermeit M, Brown JM. The effects of public managed care on patterns of intensive use of inpatient psychiatric services. Psychiatric Services. 1998;49:327–332
  22. Gerstein DR, Johnson RA, Harwood HJ, Fountain D, Suter N, Malloy K. Evaluating recovery services: The California drug and alcohol treatment assessment (CALDATA). Chicago: National Opinion Research Center at the University of Chicago; 1994;
  23. Goethe JW, Dornelas EA, Gruman C. Predicting service utilization after psychiatric hospitalization. Comprehensive Psychiatry. 1999;40:192–197
  24. Goethe JW, Fisher EH, Dornelas EA. Assessing outcomes: Identifying psychiatric patients with severe and persistent illness. Connecticut Medicine. 1997;61:559–564
  25. Gold MR, Siegel JE, Russell LB, Weinstein MC. Cost-effectiveness in health and medicine. New York: Oxford University; 1996;
  26. Harwood HJ, Hubbard RL, Collins JJ, Rachal JV. The costs of crime and the benefits of drug abuse treatment. In:  Leukefeld CG,  Tims FM editor. Compulsory treatment of drug abuse. Rockville, MD: NIDA; 1995;p. 209–235
  27. Hayes RA, Andrews N, Baron-Jeffrey M, Conley C, Grindley K, Norman R, et al. Service enhancement to a dual-diagnosis population: Mental illness/substance abuse (MISA). Quality Management in Health Care. 2003;12:133–150
  28. Hopko DR, Lachar D, Bailley SE, Varner RV. Assessing predictive factors for extended hospitalization at acute psychiatric admission. Psychiatric Services. 2001;52:1367–1373
  29. Huff ED. Outpatient utilization patterns and quality outcomes after first acute episode of mental health hospitalization. Evaluation & the Health Professions. 2000;23:441–456
  30. Jerrell JM, Ridgely MS. Evaluating changes in symptoms and functioning of dually diagnosed clients in specialized treatment. Psychiatric Services. 1995;46:233–251
  31. Lehman AF, Myers CP, Dixon LB, Johnson JL. Defining subgroups of dual diagnosis patients for service planning. Hospital & Community Psychiatry. 1994;45:556–561
  32. Lyons JS, O'Mahoney MT, Miller SI, Neme J, Kabat J, Miller F. Predicting readmission to the psychiatric hospital in a managed care environment. American Journal of Psychiatry. 1997;154:449–450
  33. MacCallum RC, Zhang S, Preacher KJ, Rucker DD. On the practice of dichotomization of quantitative variables. Psychological Methods. 2002;7:19–40
  34. Magura S, Staines G, Kosanke N, Rosenblum A, Foote J, DeLuca A, et al. Predictive validity of the ASAM patient placement. American Journal on Addictions. 2003;12:386–397
  35. Mattson ME, Allen JP, Longabaugh R, Nickless CJ, Connors GJ, Kadden RM. A chronological review of empirical studies matching alcoholic clients to treatment. Journal of Studies on Alcohol. 1994;12:16–29
  36. McCollister KE, French MT. The relative contribution of outcome domains in the total economic benefit of addiction interventions: A review of first findings. Addiction. 2003;98:1647–1659
  37. McLellan AT, Kushner H, Metzger D, Peters R, Smith I, Grisson G, et al. The fifth edition of the addiction severity index. Journal of Substance Abuse Treatment. 1992;9:461–480
  38. McLellan AT, Luborsky L, Cacciola J, Griffith J, Evans F, Barr HL, et al. New data from the addiction severity index. Journal of Nervous and Mental Disease. 1985;173:412–423
  39. McLellan AT, Woody GE, Luborsky L, O'Brien CP, Druley KA. Increased effectiveness of substance abuse treatment. Journal of Nervous and Mental Disease. 1983;171:597–605
  40. Moos RH, Schaefer J, Andrassy J, Moos BS. Outpatient mental health care, self-help groups, and patients' one-year treatment outcomes. Journal of Clinical Psychology. 2001;57:273–287
  41. Mueser K, Noordsy D, Drake R, Fox L. Integrated treatment for dual disorders. New York: Guilford; 2003;
  42. Nuttbrock LA, Rahav M, Rivera JJ, Ng-Mak DS, Link BG. Outcomes of homeless mentally ill chemical abusers in community residences and a therapeutic community. Psychiatric Services. 1998;49:68–76
  43. Ouimette PC, Ahrens C, Moos RH, Finney JW. During treatment changes in substance abuse patients with posttraumatic stress disorder. Journal of Substance Abuse Treatment. 1998;15:555–564
  44. Pacione T, Jaskula D. Quality chemical dependency treatment in an era of cost containment: Clinical guidelines for practitioners. Health and Social Work. 1994;19:55–62
  45. Phibbs C, Bhandari A, Yu W, Barnett PG. Estimating the costs of VA ambulatory care. Medical Care Research and Review. 2003;60:54S–73S
  46. Rodgers JH, Barnett PG. Two separate tracks? A national multivariate analysis of differences between public and private substance abuse treatment programs. American Journal of Drug and Alcohol Abuse. 2000;26:429–442
  47. Rosenheck R, Desai R, Steinwachs D, Lehman A. Benchmarking treatment of schizophrenia. Journal of Nervous and Mental Disease. 2000;188:209–216
  48. Rosenheck R, Seibyl CL. Effectiveness of treatment elements in a residential–work therapy program for veterans with severe substance abuse. Psychiatric Services. 1997;48:928–935
  49. Simpson DD, Joe GW, Fletcher BW, Hubbard RL, Anglin MD. A national evaluation of treatment outcomes for cocaine dependence. Archives of General Psychiatry. 1999;56:507–514
  50. Sledge WH, Tebes J, Rakfeldt J, Davidson L, Lyons L, Druss B. Day hospital/crisis respite care versus inpatient care, part I: Clinical outcomes. American Journal of Psychiatry. 1996;153:1065–1073
  51. Stoffelmayr BE, Mavis BE, Kasim RM. The longitudinal stability of the addiction severity index. Journal of Substance Abuse Treatment. 1994;11:373–378
  52. Thornton CC, Gottheil E, Weinstein SP, Karachsky RS. Patient–treatment matching in substance abuse. Journal of Substance Abuse Treatment. 1998;15:505–511
  53. Timko C. Policies and services in residential substance abuse programs: Comparisons with psychiatric programs. Journal of Substance Abuse. 1995;7:43–59
  54. Timko, C., Chen, S., Sempel, J. M., Barnett, P. G. (in press). Dual diagnosis patients in community or hospital care: 1-year outcomes and health care utilization and costs. Journal of Mental Health.
  55. Timko C, Lesar M, Engelbrekt M, Moos RH. Changes in services and structure among residential substance abuse treatment facilities. Psychiatric Services. 2000;51:494–498
  56. Timko C, Moos RH. Choice, control, and adaptation among elderly residents of sheltered care settings. Journal of Applied Social Psychology. 1989;19:636–655
  57. Timko C, Moos RH. Symptom severity, amount of treatment, and 1-year outcomes among dual diagnosis patients. Administration and Policy in Mental Health. 2002;30:35–54
  58. Timko C, Nguyen AQ, Williford WO, Moos RH. Quality of care and outcomes of chronic mentally ill patients in hospitals and nursing homes. Hospital & Community Psychiatry. 1993;44:241–246
  59. Timko C, Sempel JM. Short-term outcomes of matching dual diagnosis patients' symptom severity to treatment intensity. Journal of Substance Abuse Treatment. 2004;26:209–218
  60. Torrance GW, Feeny D. Utilities and quality-adjusted life years. International Journal of Technology Assessment in Health Care. 1989;5:559–575
  61. Wagner TH, Chen S, Yu W, Barnett PG. HERC's inpatient average cost dataset for VA care. Menlo Park, CA: VA HERC; 2003;
  62. Walker R, Minor-Schork D, Bloch R, Esinhart J. High risk factors for rehospitalization within six months. Psychiatric Quarterly. 1996;67:235–243
  63. Waltman D. Key ingredients to effective addictions treatment. Journal of Substance Abuse Treatment. 1995;12:429–439

PII: S0740-5472(06)00095-X

doi: 10.1016/j.jsat.2006.03.015

Journal of Substance Abuse Treatment
Volume 31, Issue 1 , Pages 95-105 , July 2006

Article Tools